REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 10,120
-30 (-0.30%)
At close: Oct 2, 2026
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 185.61 billion as of October 2, 2026. Its market cap has decreased by -15.74% in one year.
Market Cap
185.61B
Enterprise Value
395.43B
Revenue
143.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,120.00
ChartMarket Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 185.61B, an increase of 12.80%. That is a compound annual growth rate of 0.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 185.61B | -6.12% |
| Dec 30, 2025 | 197.72B | -16.04% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BNC KOREA | 223.99B |
| Suheung | 223.84B |
| AptaBio Therapeutics | 216.04B |
| Yungjin Pharm. | 193.32B |
| FutureChem Co.,Ltd | 190.23B |
| Whan In Pharm | 187.06B |
| Chong Kun Dang Holdings | 178.28B |
| Samil Pharmaceutical Co.,Ltd | 175.24B |